3 No-Brainer Stocks to Buy in July [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Three Fool.com contributors think they have solutions for those investors who don't want to think too hard. Here's why they picked Eli Lilly (NYSE: LLY) Regeneron Pharmaceuticals (NASDAQ: REGN) , and Vertex Pharmaceuticals (NASDAQ: VRTX) as no-brainer biotech stocks to buy in July. Eli Lilly is likely to surpass $1 trillion in value David Jagielski (Eli Lilly): One of the best growth stocks you can buy right now is Eli Lilly. The healthcare company has plenty of growth catalysts in its portfolio, which can pave the way for its valuation to soar past $1 trillion. Today, it has diabetes treatment Mounjaro and recently approved weight loss drug Zepbound, which together have generated $2.3 billion in revenue in the first three months of the year. Mounjaro is now the company's top-selling drug, overtaking Trulicity. And there's much more growth ahead. Eli Lilly may have a couple of more promising weight-loss products to add to its growing portfolio. Retatrutide is in phase 3 tria
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- What end of Eli Lilly's weight-loss drug shortage means for the competition [Yahoo! Finance Canada]Yahoo! Finance Canada
- Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list [Yahoo! Finance Canada]Yahoo! Finance Canada
- What end of Eli Lilly's weight-loss drug shortage means for the competition [Yahoo! Finance]Yahoo! Finance
- England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access [Yahoo! Finance]Yahoo! Finance
- NHS proposes phased launch for Eli Lilly's Mounjaro [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 8/8/24 - Beat
LLY
Sec Filings
- 9/18/24 - Form 3
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- LLY's page on the SEC website